- Home
- MBLY vs HIMS Comparison
MBLY vs HIMS Comparison
Compare MBLY & HIMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MBLY
- HIMS
- Stock Information
- Founded
- MBLY 1999
- HIMS 2017
- Country
- MBLY Israel
- HIMS United States
- Employees
- MBLY N/A
- HIMS N/A
- Industry
- MBLY Computer Software: Prepackaged Software
- HIMS Medical/Nursing Services
- Sector
- MBLY Technology
- HIMS Health Care
- Exchange
- MBLY Nasdaq
- HIMS Nasdaq
- Market Cap
- MBLY 10.9B
- HIMS 12.2B
- IPO Year
- MBLY 2022
- HIMS N/A
- Fundamental
- Price
- MBLY $12.52
- HIMS $38.73
- Analyst Decision
- MBLY Buy
- HIMS Hold
- Analyst Count
- MBLY 17
- HIMS 12
- Target Price
- MBLY $19.44
- HIMS $42.80
- AVG Volume (30 Days)
- MBLY 4.7M
- HIMS 29.8M
- Earning Date
- MBLY 10-23-2025
- HIMS 11-03-2025
- Dividend Yield
- MBLY N/A
- HIMS N/A
- EPS Growth
- MBLY N/A
- HIMS 20.76
- EPS
- MBLY N/A
- HIMS 0.54
- Revenue
- MBLY $1,938,000,000.00
- HIMS $2,210,958,000.00
- Revenue This Year
- MBLY $15.48
- HIMS $61.73
- Revenue Next Year
- MBLY $7.59
- HIMS $19.43
- P/E Ratio
- MBLY N/A
- HIMS $72.68
- Revenue Growth
- MBLY 7.61
- HIMS 78.02
- 52 Week Low
- MBLY $11.58
- HIMS $19.15
- 52 Week High
- MBLY $22.51
- HIMS $72.98
- Technical
- Relative Strength Index (RSI)
- MBLY 38.04
- HIMS 31.67
- Support Level
- MBLY $12.26
- HIMS $39.34
- Resistance Level
- MBLY $13.10
- HIMS $42.70
- Average True Range (ATR)
- MBLY 0.51
- HIMS 2.78
- MACD
- MBLY -0.06
- HIMS -0.65
- Stochastic Oscillator
- MBLY 12.36
- HIMS 4.32
About MBLY Mobileye Global Inc.
Mobileye Global Inc engages in the development and deployment of ADAS and autonomous driving technologies and solutions. It is building a portfolio of end-to-end ADAS and autonomous driving solutions to provide the capabilities needed for the future of autonomous driving, leveraging a comprehensive suite of purpose-built software and hardware technologies. The company's reportable operating segment are Mobileye and Others. Its solutions comprise Driver Assist, Cloud-Enhanced Driver Assist, Mobileye SuperVision Lite, Mobileye SuperVision, Mobileye Chauffeur, Mobileye Drive, Self-Driving System & Vehicles. It derives maximum revenue from Mobileye Segment.
About HIMS Hims & Hers Health Inc.
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.